A Phase 3, Long-Term, Open-Label Study of Difamilast Ointment to Evaluate Efficacy and Safety in Japanese Infants with Atopic Dermatitis

Authors

Institutions

Publication Details

Journal
Dermatology and Therapy
Published
2025-10-31
DOI
https://doi.org/10.1007/s13555-025-01581-1
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Phase 3, Long-Term, Open-Label Study of Difamilast Ointment to Evaluate Efficacy and Safety in Japanese Infants with Atopic Dermatitis

Naoko Baba, Hidehisa Saeki, Yukihiro Ohya, Daisuke Yokota et al.
Dermatology and Therapy
Dermatology and Skin Diseases
article

A Phase 3, Long-Term, Open-Label Study of Difamilast Ointment to Evaluate Efficacy and Safety in Japanese Infants with Atopic Dermatitis

Naoko Baba, Hidehisa Saeki, Yukihiro Ohya, Daisuke Yokota, Tomomi Imamura, Hidetsugu Tsubouchi
article en

Abstract

No abstract available for this paper.
Dermatology and TherapyVol. 16(1)
Otsuka (Japan) (JP), Nagoya City University (JP), Kanagawa Children's Medical Center (JP), Fujita Health University Hospital (JP), National Center For Child Health and Development (JP), Nippon Medical School (JP)
Eli Lilly and Company, Eisai, Otsuka Pharmaceutical, LEO Pharma, Eli Lilly Japan
Openalex Percentile: Top 47%
Dermatology and Skin Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.